ES2055193T3 - Nuevo epimero de 1 alfa-hidroxi-vitamina d2 y derivados. - Google Patents

Nuevo epimero de 1 alfa-hidroxi-vitamina d2 y derivados.

Info

Publication number
ES2055193T3
ES2055193T3 ES90104564T ES90104564T ES2055193T3 ES 2055193 T3 ES2055193 T3 ES 2055193T3 ES 90104564 T ES90104564 T ES 90104564T ES 90104564 T ES90104564 T ES 90104564T ES 2055193 T3 ES2055193 T3 ES 2055193T3
Authority
ES
Spain
Prior art keywords
vitamin
hydroxy
new
alpha
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90104564T
Other languages
English (en)
Inventor
Hector F Deluca
Heinrich K Schnoes
Kato L Perlman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of ES2055193T3 publication Critical patent/ES2055193T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL INVENTO PROVEE UN NUEVO COMPONENTE D2 VITAMIN, D2 VITAMIN-EPI-24-HIDROXI-1A Y CIERTOS DERIVADOS DE ELLO PROTEGIDOS DE HIDROXI. LOS NUEVOS COMPONENTES EXHIBEN UN MODELO DE ACTIVIDAD DISTINTIVA COMPRENDIENDO ALTA POTENCIA EN ESTIMULAR EL TRANSPORTE DE CALCIO INTESTINAL Y PEQUEÑA O NINGUNA ACTIVIDAD EN INDUCIR LA MOVILIZACION DE CALCIO DE HUESO O LA DIFERENCIACION DE CELULAS INDIFERENCIADAS EN CULTIVO, POR LO CUAL MOSTRAR UTILIDAD EN EL TRATAMIENTO DE ENFERMEDADES CARACTERIZADAS POR LA PERDIDA DE MASA OSEA.
ES90104564T 1989-03-09 1990-03-09 Nuevo epimero de 1 alfa-hidroxi-vitamina d2 y derivados. Expired - Lifetime ES2055193T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/321,254 US4973584A (en) 1989-03-09 1989-03-09 Novel 1α-hydroxyvitamin D2 epimer and derivatives

Publications (1)

Publication Number Publication Date
ES2055193T3 true ES2055193T3 (es) 1994-08-16

Family

ID=23249837

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90104564T Expired - Lifetime ES2055193T3 (es) 1989-03-09 1990-03-09 Nuevo epimero de 1 alfa-hidroxi-vitamina d2 y derivados.

Country Status (15)

Country Link
US (1) US4973584A (es)
EP (1) EP0386793B1 (es)
JP (1) JPH0737443B2 (es)
KR (1) KR950005776B1 (es)
AT (1) ATE90342T1 (es)
AU (1) AU631618B2 (es)
CA (1) CA1335105C (es)
DE (1) DE69001839T2 (es)
DK (1) DK0386793T3 (es)
ES (1) ES2055193T3 (es)
HU (1) HU207040B (es)
IL (1) IL93456A (es)
NZ (1) NZ232735A (es)
RU (1) RU2065851C1 (es)
WO (1) WO1990010619A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
US5756783A (en) * 1990-09-21 1998-05-26 Bone Care International, Inc. 1α-Hydroxy-24-EPI-vitamin D4
US5786348A (en) * 1991-01-08 1998-07-28 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US6251883B1 (en) 1991-01-08 2001-06-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US5182396A (en) * 1991-03-29 1993-01-26 Nisshin Flour Milling Co., Ltd. 1-hydroxyvitamin d derivatives
ATE144250T1 (de) * 1991-12-26 1996-11-15 Wisconsin Alumni Res Found 26,27-dimethylen-1-alpha, 25-dihydroxyvitamin-d2 und 26,27-dihydroxyvitamin-d2 und verfahren zu ihrer herstellung
WO1993014763A1 (en) * 1992-01-29 1993-08-05 Lunar Corporation 1α-HYDROXY-24-EPI-VITAMIN D¿4?
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
DE69325253T2 (de) * 1992-08-28 1999-12-02 Bone Care Int Inc 1alpha,24(s)-dihydroxy vitamin d2, seine synthese und verwendung
TW267161B (es) * 1992-11-20 1996-01-01 Hoffmann La Roche
JPH0753384A (ja) * 1993-07-13 1995-02-28 Wisconsin Alumni Res Found ２４−エピ−１α−ヒドロキシビタミンＤ２ を含んでなる骨粗鬆症治療剤
US5565589A (en) * 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
US5373004A (en) * 1993-11-24 1994-12-13 Wisconsin Alumni Research Foundation 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
US5661140A (en) * 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
AU1525700A (en) 1998-11-19 2000-06-05 Board Of Trustees Of The University Of Arkansas, The Increasing bone strength with selected bisphosphonates
PT1180035E (pt) * 1999-04-01 2007-02-28 Univ Johns Hopkins Análogos não calcémicos, antiproliferativos, transcricionalmente activos de 1-alfa, 25-di-hidroxivitamina d3 contendo enxofre
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
CA2458415C (en) * 2001-08-22 2010-09-21 Johns Hopkins University 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3
EP1511725B1 (en) 2002-06-13 2012-02-01 Johns Hopkins University 24-sulfoximine vitamin d3 compounds
CA2510228C (en) 2002-12-18 2012-10-30 Johns Hopkins University 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
CA2535185C (en) * 2003-08-20 2013-04-23 Wisconsin Alumni Research Foundation 2-methylene-19-nor-vitamin d2 compounds
EA201691980A1 (ru) 2009-01-27 2017-07-31 БЕРГ ЭлЭлСи Способы уменьшения побочных эффектов, связанных с химиотерапией
SG178382A1 (en) 2009-08-14 2012-04-27 Berg Biosystems Llc Vitamin d3 and analogs thereof for treating alopecia
WO2014194133A1 (en) 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907843A (en) * 1974-06-14 1975-09-23 Wisconsin Alumni Res Found 1{60 -Hydroxyergocalciferol and processes for preparing same
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
DE3448412C2 (es) * 1983-05-09 1991-12-12 Wisconsin Alumni Res Found
US4769181A (en) * 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
US4717721A (en) * 1985-05-30 1988-01-05 Howard W. Bremer Sidechain homo-vitamin D compounds with preferential anti-cancer activity

Also Published As

Publication number Publication date
KR950005776B1 (ko) 1995-05-30
ATE90342T1 (de) 1993-06-15
US4973584A (en) 1990-11-27
IL93456A0 (en) 1990-11-29
DK0386793T3 (da) 1993-08-02
AU5192590A (en) 1990-10-09
DE69001839T2 (de) 1993-09-16
IL93456A (en) 1994-02-27
JPH0737443B2 (ja) 1995-04-26
RU2065851C1 (ru) 1996-08-27
KR920700201A (ko) 1992-02-19
HU902288D0 (en) 1991-07-29
HU207040B (en) 1993-03-01
WO1990010619A1 (en) 1990-09-20
NZ232735A (en) 1992-07-28
JPH03504508A (ja) 1991-10-03
EP0386793A1 (en) 1990-09-12
AU631618B2 (en) 1992-12-03
DE69001839D1 (de) 1993-07-15
EP0386793B1 (en) 1993-06-09
CA1335105C (en) 1995-04-04

Similar Documents

Publication Publication Date Title
ES2055193T3 (es) Nuevo epimero de 1 alfa-hidroxi-vitamina d2 y derivados.
NO873950D0 (no) Biologisk absorberbart belegg for kirurgisk artikkel.
ES515033A0 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
PT1061940E (pt) Utilizacao de foliestatina para a producao de um medicamento para o tratamento de disturbios relacionados com os musculos
GEP19991834B (en) Crystalline Oxathiolane Derivatives
FR2615097B1 (fr) Impacteur-extracteur de prothese notamment de hanche
EP0494231A4 (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
ATE70069T1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglyko e und antibiotika-a40926-aglykone.
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
EP0998941A4 (en) MEDICINAL PRODUCTS CONTAINING MIDKINE AS ACTIVE INGREDIENT OR INHIBITORS OF SUCH MEDICINAL PRODUCTS
NZ235610A (en) Treating bone diseases with bafilomycin-type compounds
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
GB2179858B (en) Compositions for treating viral skin diseases.
ES2019053A4 (es) Centro quirurgico modular ambulatorio.
DE69331231T2 (de) Ein neuartiges, antineoplastisches cytokin
FR2637465B1 (fr) Procede de conservation, notamment d'algues fraiches
NZ222375A (en) Controlling plant disease or microorganisms using n-halohydantoins
PT85229A (fr) Procede de preparation des variants de l:alpha-antitrysine humaine glycosylee et vecteurs viral d:expression de l:alpha1-at
DK552889D0 (da) Coleopteran-aktive mikroorganismer, beslaegtede insekticide midler og fremgangsmaade til deres fremstilling og anvendelse
PL280451A1 (en) Biological treatment plant
PL282470A1 (en) Biological treatment plant
PL280698A1 (en) Moumtain biological treatment plant
PL280252A1 (en) Biological treatment plant
FR2643790B1 (fr) Procede de fumigation
IE883281L (en) Treating bone diseases

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 386793

Country of ref document: ES